FR2372827A1 - Composes polycycliques azotes et leurs utilisations therapeutiques comme hypotenseurs - Google Patents
Composes polycycliques azotes et leurs utilisations therapeutiques comme hypotenseursInfo
- Publication number
- FR2372827A1 FR2372827A1 FR7736243A FR7736243A FR2372827A1 FR 2372827 A1 FR2372827 A1 FR 2372827A1 FR 7736243 A FR7736243 A FR 7736243A FR 7736243 A FR7736243 A FR 7736243A FR 2372827 A1 FR2372827 A1 FR 2372827A1
- Authority
- FR
- France
- Prior art keywords
- hypotensors
- therapeutic uses
- polycyclic compounds
- nitrogen
- nitrogen polycyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Ces composés répondent à la formule :
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/746,657 US4093726A (en) | 1976-12-02 | 1976-12-02 | N-(2-benzimidazolyl)-piperazines |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2372827A1 true FR2372827A1 (fr) | 1978-06-30 |
Family
ID=25001779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7736243A Withdrawn FR2372827A1 (fr) | 1976-12-02 | 1977-12-01 | Composes polycycliques azotes et leurs utilisations therapeutiques comme hypotenseurs |
Country Status (5)
Country | Link |
---|---|
US (1) | US4093726A (fr) |
JP (1) | JPS5371088A (fr) |
CA (1) | CA1086725A (fr) |
FR (1) | FR2372827A1 (fr) |
GB (1) | GB1583357A (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0389765A1 (fr) * | 1989-02-10 | 1990-10-03 | Merrell Dow Pharmaceuticals Inc. | Antagonistes du calcium |
US5106845A (en) * | 1990-01-10 | 1992-04-21 | Merrell Dow Pharmaceuticals Inc. | Calcium antagonists |
EP0548798A1 (fr) * | 1991-12-18 | 1993-06-30 | Sanwa Kagaku Kenkyusho Co., Ltd. | Agent antiviral |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4375470A (en) * | 1980-02-04 | 1983-03-01 | American Home Products Corporation | 2(1-Piperazinyl)-cycloheptimidazole antihypertensive composition and methods |
US4258188A (en) * | 1980-02-04 | 1981-03-24 | American Home Products Corporation | 2-(1-Piperazinyl)-cycloheptimidazole derivatives |
US4333937A (en) * | 1980-04-18 | 1982-06-08 | American Home Products Corp. | 2-(Piperazinyl)-4-pyrimioinamines |
US4351832A (en) * | 1980-04-18 | 1982-09-28 | American Home Products Corporation | 2-(Piperazinyl)-4-pyrimidinamines |
JPS5879983A (ja) * | 1981-11-06 | 1983-05-13 | Kanebo Ltd | 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物 |
JPS59199679A (ja) * | 1983-04-27 | 1984-11-12 | Kanebo Ltd | 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物 |
TW201744B (fr) * | 1991-07-02 | 1993-03-11 | Kanebou Textile Co Ltd | |
PT100905A (pt) * | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem |
ES2072193B1 (es) * | 1993-05-21 | 1996-02-16 | Espanola Prod Quimicos | Nuevos derivados del1-fenilmetil bencimidazol piperacinas. |
US6313294B1 (en) | 1998-02-04 | 2001-11-06 | Development Center For Biotechnology | Process for preparing amides |
BR9915013A (pt) | 1998-11-03 | 2001-08-07 | Basf Ag | Composto, uso dos mesmos, processo para preparar os mesmos, droga, e, método para detecção in vitro para inibidores parp |
HUP0200749A3 (en) | 1998-11-27 | 2003-03-28 | Basf Ag | Substituted benzimidazoles and their use as parp inhibitors and process for their preparation |
EP1165084A4 (fr) * | 1999-03-03 | 2002-05-15 | Merck & Co Inc | Inhibiteurs de prenyl-proteine transferases |
AU3390000A (en) * | 1999-03-03 | 2000-09-21 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
GB9914825D0 (en) * | 1999-06-24 | 1999-08-25 | Smithkline Beecham Spa | Novel compounds |
TWI225488B (en) * | 1999-12-21 | 2004-12-21 | Janssen Pharmaceutica Nv | Derivatives of homopiperidinyl substituted benzimidazole analogues |
US20070004713A1 (en) * | 2000-12-07 | 2007-01-04 | Bernard Barlaam | Therapeutic benimidazole compounds |
JP2006505570A (ja) * | 2002-10-17 | 2006-02-16 | アムジエン・インコーポレーテツド | ベンズイミダゾール誘導体およびそれのバニロイド受容体リガンドとしての使用 |
AU2006235759B2 (en) * | 2005-04-06 | 2011-07-28 | Msd K.K. | 1,4-substituted piperazine derivative |
TWI375673B (en) * | 2005-04-11 | 2012-11-01 | Abbott Lab | 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors |
US7728026B2 (en) * | 2005-04-11 | 2010-06-01 | Abbott Laboratories, Inc. | 2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors |
EP1957477B1 (fr) * | 2005-09-29 | 2011-12-07 | Abbott Laboratories | 1h-benzimidazole-4-carboxamides a substitution phenyle en position 2, utilises comme inhibiteurs de la parp |
TW200736229A (en) * | 2005-11-15 | 2007-10-01 | Abbott Lab | Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors |
ES2462240T3 (es) * | 2006-02-28 | 2014-05-22 | Dart Neuroscience (Cayman) Ltd | Piperazinas terapéuticas como inhibidores de PDE4 |
US8927546B2 (en) * | 2006-02-28 | 2015-01-06 | Dart Neuroscience (Cayman) Ltd. | Therapeutic piperazines |
US8685961B2 (en) * | 2006-03-29 | 2014-04-01 | Merck Sharp & Dohme Corp. | Diazepan orexin receptor antagonists |
ATE553104T1 (de) * | 2006-05-02 | 2012-04-15 | Abbott Lab | Substituierte 1h-benzimidazol-4-carboxamide als potente parp-hemmer |
US8067613B2 (en) * | 2007-07-16 | 2011-11-29 | Abbott Laboratories | Benzimidazole poly(ADP ribose)polymerase inhibitors |
WO2010083199A1 (fr) * | 2009-01-19 | 2010-07-22 | Abbott Laboratories | Inhibiteurs benzthiazole de la poly(adp-ribose)polymérase |
FR3000065A1 (fr) * | 2012-12-21 | 2014-06-27 | Univ Lille Ii Droit & Sante | Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes |
CA3066361A1 (fr) | 2017-06-07 | 2018-12-13 | Shifamed Holdings, Llc | Dispositifs de deplacement de fluide intravasculaire, systemes et procedes d'utilisation |
US11511103B2 (en) | 2017-11-13 | 2022-11-29 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
WO2019152875A1 (fr) | 2018-02-01 | 2019-08-08 | Shifamed Holdings, Llc | Pompes à sang intravasculaires et méthodes d'utilisation et procédés de fabrication |
JP2022540616A (ja) | 2019-07-12 | 2022-09-16 | シファメド・ホールディングス・エルエルシー | 血管内血液ポンプならびに製造および使用の方法 |
WO2021016372A1 (fr) | 2019-07-22 | 2021-01-28 | Shifamed Holdings, Llc | Pompes à sang intravasculaires à entretoises et procédés d'utilisation et de fabrication |
WO2021062265A1 (fr) | 2019-09-25 | 2021-04-01 | Shifamed Holdings, Llc | Dispositifs et systèmes de pompes à sang intravasculaires et leurs procédés d'utilisation et de commande |
WO2021062270A1 (fr) | 2019-09-25 | 2021-04-01 | Shifamed Holdings, Llc | Pompes à sang de cathéter et boîtiers de pompe pliables |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS50126682A (fr) * | 1974-03-25 | 1975-10-04 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3574218A (en) * | 1969-08-11 | 1971-04-06 | Egyt Gyogyszervegyeszeti Gyar | 2-aryl- or aralkyl-substituted benzazole derivatives |
BE787059A (fr) * | 1971-08-03 | 1973-02-01 | Wander Ag Dr A | Nouveaux derives du thiazole, leur preparation et leur application comme medicaments |
DE2436883C2 (de) * | 1974-07-29 | 1985-08-22 | Schering AG, 1000 Berlin und 4709 Bergkamen | Benzimidazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
-
1976
- 1976-12-02 US US05/746,657 patent/US4093726A/en not_active Expired - Lifetime
-
1977
- 1977-11-17 CA CA291,125A patent/CA1086725A/fr not_active Expired
- 1977-11-30 JP JP14286477A patent/JPS5371088A/ja active Pending
- 1977-12-01 FR FR7736243A patent/FR2372827A1/fr not_active Withdrawn
- 1977-12-01 GB GB50133/77A patent/GB1583357A/en not_active Expired
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS50126682A (fr) * | 1974-03-25 | 1975-10-04 |
Non-Patent Citations (1)
Title |
---|
CA1976 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0389765A1 (fr) * | 1989-02-10 | 1990-10-03 | Merrell Dow Pharmaceuticals Inc. | Antagonistes du calcium |
US5106845A (en) * | 1990-01-10 | 1992-04-21 | Merrell Dow Pharmaceuticals Inc. | Calcium antagonists |
EP0548798A1 (fr) * | 1991-12-18 | 1993-06-30 | Sanwa Kagaku Kenkyusho Co., Ltd. | Agent antiviral |
Also Published As
Publication number | Publication date |
---|---|
JPS5371088A (en) | 1978-06-24 |
GB1583357A (en) | 1981-01-28 |
US4093726A (en) | 1978-06-06 |
CA1086725A (fr) | 1980-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2372827A1 (fr) | Composes polycycliques azotes et leurs utilisations therapeutiques comme hypotenseurs | |
FR2453145A1 (fr) | ||
FR2366278A1 (fr) | Esters et amides maloniques de piperidyle-4 utilisables comme stabilisants de matieres plastiques | |
FR2359115A1 (fr) | Derives tetraalkyles de bis-cyclohexylamines et leur preparation | |
FR2392978A2 (fr) | Naphtalimides substitues utilisables comme medicaments | |
FR2392007A1 (fr) | 3,3,3-triarylalkyl-4-phenylalkyl-4-hydroxy-piperidines, leurs derives, leur preparation et leur utilisation comme antidiarrheiques et analgesiques | |
FR2387192A1 (fr) | Conducteurs cationiques amorphes du lithium | |
FR2390960A1 (fr) | Composes steroliques 15-oxygenes, ainsi que leur application dans l'inhibition de la biosynthese de l'acide mevalonique | |
FR2430418A1 (fr) | Derives halogenomethyles d'a-aminoacides, leur preparation et leurs utilisations therapeutiques | |
FR2417515A1 (fr) | 13-alkylthio (et arylthio)-11,17-epoxy-17-methyl-18-norandrostenes et leurs utilisations therapeutiques | |
FR2427335A1 (fr) | Derives du 5-nitro-imidazole, leur preparation et leurs utilisations comme medicaments antiprotozoaires | |
FR2422658A1 (fr) | Composes piperazinyl-benzoheterocycliques, leur preparation et leurs utilisations therapeutiques | |
FR2367745A1 (fr) | Bis-polyalkyl-piperidines utilisables comme stabilisants de matieres plastiques | |
FR2361887A1 (fr) | Derives du resorcinol, leur preparation et leurs utilisations therapeutiques | |
FR2377396A1 (fr) | Dithienylalkylamines, leur preparation et leurs utilisations therapeutiques | |
FR2387269A1 (fr) | Melanges de colorants azoiques, leur preparation et leurs utilisations | |
FR2368521A1 (fr) | Colorants reactifs | |
FR2442226A1 (fr) | Anilines substituees, leur preparation et leurs utilisations | |
FR2383163A1 (fr) | Derives aromatiques et azotes de l'acetamide, leur preparation et leur utilisation therapeutique comme anti-arythmiques | |
FR2372164A1 (fr) | Pyridobenzodiazepinones, leur preparation et leurs utilisations therapeutiques | |
FR2387215A1 (fr) | 4-alcoylthio-2-trifluoromethylalcanesulfonanilides et leurs derives | |
FR2381030A1 (fr) | Phenylaminomethyl-2 imidazolines et leur preparation | |
FR2426690A2 (fr) | Composes de rifamycine | |
FR2375223A1 (fr) | 1,2,6-thiadiazinones, leur preparation et leurs utilisations | |
FR2372792A1 (fr) | Aminoalcoxybenzenes, leur preparation et leurs utilisations therapeutiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |